Xilio Therapeutics XLO
NASDAQ XLO
$7.90 -0.13 (-1.62%)
As of: Oct 23, 2026 · 2:36 PM EDT

Xilio Therapeutics (XLO) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Xilio Therapeutics (XLO) recorded Return on Capital Employed [ROCE] of -25.16% in Q2 2026, up 61.26 percentage points from -86.42% a year earlier and up 11.22 percentage points from the prior quarter.

Analysis

Xilio Therapeutics (XLO) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Xilio Therapeutics reported Return on Capital Employed [ROCE] of -74.16%, up 82.22 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a four-year change of -8.57 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -156.38% in FY2024 (-62.28 pp), -94.11% in FY2023 (-37.50 pp), -56.60% in FY2022 (+8.99 pp) and -65.59% in FY2021.
  • The Q2 2026 figure is the highest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2021.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for seven consecutive quarters, with an average year-over-year change of +53.72 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 106.85 percentage points in Q1 2026, against a drop of 98.10 percentage points in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -36.38% (Q1 2026), -47.75% (Q4 2025) and -56.59% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,127.89 Bn 1,096.47 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.11 Bn 554.97 Bn 17.30 Bn 17.52%
3 AbbVie 504.69 Bn 477.80 Bn 12.70 Bn 17.92%
4 Merck 358.24 Bn 312.62 Bn 12.21 Bn 6.28%
5 Novartis Ag 290.13 Bn 254.12 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn 16.76%
7 Amgen 237.87 Bn 193.27 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.91 Bn 169.11 Bn 6.22 Bn -5.97%
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn 11.86%
10 Xilio Therapeutics 153.30 Mn -374.37 Mn - -25.16%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25.16%
Mar 31, 2026 -36.38%
Dec 31, 2025 -47.75%
Sep 30, 2025 -56.59%
Jun 30, 2025 -86.42%
Mar 31, 2025 -143.23%
Dec 31, 2024 -132.84%
Sep 30, 2024 -147.10%
Jun 30, 2024 -142.19%
Mar 31, 2024 -181.89%
Dec 31, 2023 -148.11%
Sep 30, 2023 -123.47%
Jun 30, 2023 -101.61%
Mar 31, 2023 -83.79%
Dec 31, 2022 -70.10%
Sep 30, 2022 -56.67%
Jun 30, 2022 -47.97%
Mar 31, 2022 -40.90%
Dec 31, 2021 -47.92%
API Access

Xilio Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=XLO&period=max&api_key=YOUR_API_KEY